[Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
作者信息
Goette A
机构信息
Klinik für Kardiologie, Angiologie und Pneumologie, Otto-von-Guericke-Universitätsklinik Magdeburg.
出版信息
Dtsch Med Wochenschr. 2006 Aug 25;131(34-35 Suppl 4):S103-7. doi: 10.1055/s-2006-949185.
PMID:16921445
Abstract
摘要
相似文献
1
[Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
Dtsch Med Wochenschr. 2006 Aug 25;131(34-35 Suppl 4):S103-7. doi: 10.1055/s-2006-949185.
2
The impact of suppressing the renin-angiotensin system on atrial fibrillation.
J Clin Pharmacol. 2006 Jan;46(1):21-8. doi: 10.1177/0091270005283284.
3
Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Minerva Cardioangiol. 2007 Jun;55(3):311-5.
4
Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
Conn Med. 2007 Apr;71(4):205-9.
5
[Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Kardiol Pol. 2007 Apr;65(4):440-5.
6
Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31.
7
[The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Anadolu Kardiyol Derg. 2009 Dec;9(6):505-11.
8
Renin-angiotensin system inhibitors and atrial fibrillation.
Isr Med Assoc J. 2005 Jun;7(6):388-91.
9
Role of renin-angiotensin system inhibitors in atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2011 May;12(5):374; author reply 375. doi: 10.2459/JCM.0b013e328343d3de.
10
Atrial fibrillation and renin-angiotensin system.
Ther Adv Cardiovasc Dis. 2008 Jun;2(3):215-23. doi: 10.1177/1753944708092111.
Zotero 插件